Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 2 , Pages 73-78 , June 2009

Twenty years of experience with PDD and PDT in Poland—Review

References 

  1. Podbielska H, Bindig U, Ulatowska-Jarża A, Hołowacz I, Müller G, Scheller EE. Optical properties of sol–gel fiber optic applicators for laser interstitial therapy. Laser Phys. 2006;16(5):1–11
  2. Podbielska , Ulatowska-Jarża A, Bauer J, Wieliczko A, Razik J, Stręk W. The comparison of photodynamic activity of photolon and protoporphyrine on pathogenic bacteria in vitro. Polish J Environ Studies. 2006;15(4A):147–151
  3. In:  Podbielska H,  Sieroń A,  Stręk W editor. Aspects of Photodynamic Medicine II, Book Series Acta Biomedical Engineering. vol. 3, wyd:Wrocław: Indygo Zahir; 2008;
  4. In:  Podbielska H,  Sieroń A,  Stręk W editor. Aspects of Photodynamic Medicine I, Book Series Acta Biomedical Engineering. vol. 2, wyd:Wrocław: Kriotechnika Medyczna; 2007;
  5. In:  Podbielska H,  Sieroń A,  Stręk W editor. Diagnostyka i terapia fotodynamiczna, Photodynamic diagnostics and therapy. Wrocław: Urban & Partner; 2004;(in Polish)
  6. Ulatowska-Jarża A, Hołowacz I, Razik J, Wieliczko A, Stręk W, Czernielewski L, Podbielska H, New method for decontamination based on photodynamic activity – preliminary in vitro study on Gram-negative bacteria. Proc. of the Symposium on Photonics Technologies for the 7th Framework Program, Oficyna Wyd. Politechniki Wrocławskiej. ISBN 83-7085-970-4; 2006. pp. 324–27.
  7. Wysocka K, Buzalewicz I, Wieliczko A, Kowal K, Stręk W, Podbielska H. Biomaterials with antibacterial activity. Eng Biomater. 2008;81–84:119–121
  8. Bindig U, Ulatowska-Jarża A, Kopaczyńska M, Muller G, Podbielska H. Investigations on photolon- and porphyrin-doped sol–gel fiberoptic coatings for laser-assisted applications in medicine. Laser Phys. 2008;18(1):s.1–10
  9. Podbielska H, Hołowacz I, Bindig U, Ulatowska-Jarża A, Rohde E, Eicke-Eric S. Interstitial laser coagulation in vitro with sol–gel applicators. Interstycjalna koagulacja laserowa in vitro aplikatorami zol-żelowymi. Med Laser Appl (Elsevier). 2006;21(1):s.35–43
  10. Ulatowska-Jarża A, Zychowicz J, Hołowacz I, et al. Antimicrobial PDT with chlorophyll-derived photosensitizer and semiconductor laser. Med Laser Appl (Elsevier). 2006;21:s.177–183
  11. Podbielska H, Ulatowska-Jarża A, Muller G, Hołowacz I, Bauer J, Bindig U. Silica sol–gel matrix doped with Photolon molecules for sensing and medical therapy purposes. Biomol Eng. 2007;24(5):s.425–433
  12. Boerner E, Bauer J, Szewczyk A, Podbielska H. Laser transillumination of interphalangeal joints of women suffering from rheumatoid diseases. Opt Appl 2007;XXXVII(1–2):153–160.
  13. Kubica K, Langner M, Gabrielska J. The dependence of fluorescein-PE fluorescence intensity on lipid bilayer state. Evaluating the Interaction between the probe and lipid molecules. Cell Mol Biol Lett. 2003;8:943–954
  14. Kral T, Langner M, Hof M. DNA-spermine and DNA-lipid aggregate formation visualized by fluorescence correlation spectroscopy. Chemotherapy. 2006;52:196–199
  15. Jurkiewicz P, Olżyńska A, Langner M, Hof M. Headgroup hydration and mobility of DOTAP/DOPC bilayers: a fluorescence solvent relaxation study. Langmuir. 2006;22(21):8741–8749
  16. Kral T, Benda A, Hof M, Langner M. Some aspects of DNA condensation observed by fluorescence correlation spectroscopy. In:  Geddes CD,  Lakowicz JR editor. Rev. Fluorescence 2005. vol. 2:NY: Springer; 2005;p. 109–124
  17. Woźniacka A, Langner K, McCauliffe D, Sysa-Jędrzejowska A, Langner M. Quantitative evaluation of 52kD Ro/SS-A intracellular distribution in keratinocytes exposed to UVB radiation. Opt Appl. 2004;34:77–85
  18. Kotulska M. Electrochemotherapy in cancer treatment. Adv Clin Exp Med. 2007;16/5:601–607
  19. Kotulska M, Kubica K, Koronkiewicz S, Kalinowski S. Modeling the induction of lipid membrane electropermeabilization. Bioelectrochemistry. 2007;70(1):64–70
  20. Kotulska M. Natural fluctuations of an electropore show fractional Lévy stable motion. Biophys J. 2007;92:2412–2421
  21. Kotulska M. Electro-nanopores in the lipid membrane and their application in medicine. Warsaw: Prace Instytutu Biocybernetyki i Inżynierii Biomedycznej; 2007.
  22. Dyrka W, Augousti A, Kotulska M. Ion flux through membrane channels—an enhanced algorithm for the Poisson–Nernst–Planck model. J Comput Chem. 2008;29/12:1877–1888
  23. Olsztyńska-Janus S, Komorowska M, Vrielynck L, Dupuy N. Vibrational spectroscopic study of l-phenylalanine: effect of pH. Appl Spectrosc. 2001;55(7):s.901–907
  24. Komorowska M, Gałwa M, Herter B, Wesołowska U. Hydration effects under near-infrared radiation. Colloids Surf B. 2002;26(3):223–233
  25. Komorowska M, Czarnołęski A. Near-infrared induced membrane surface electrostatic potential, fluorescent measurements. Colloids Surf B. 2001;20(4):s.309–314
  26. Olsztyńska-Janus S, Vrielynck L, Komorowska M, Dupuy N. Why light therapy is more effective than thermotherapy in rehabilitation? W: Biomechanika 2001. Materiały XVII konferencji naukowej, Gliwice-Zakopane, 3–6.09.2001. Wrocław: Oficyna Wydaw. PWroc., 2001. Acta Bioeng Biomech 3(Suppl. 2):s.387–91.
  27. Chwałek , Kramer G, Wideł M, Ratuszna A, Habdas J. Photodynamic effect of two water-soluble porphyrins on human malignant melanoma and murine cervical carcinoma in multicellular megacolonies system in vitro. Polish J Med Phys Eng. 2000;6:185–190
  28. Drzewiecka , Urbańska K, Matuszak Z, et al. Tritolylporphyrin dimer as a new potent hydrophobic sensitizer for photodynamic therapy of melanoma. Acta Biochem Pol. 2001;48:277–282
  29. Habdas J, Machura B, Waśkowska A, Mazurak Z, Ratuszna A. Crystallographic and spectroscopic properties of meso-tetratolyloporhyrin. Ann Polish Chem Soc. 2001;10
  30. Szurko A, Kramer-Marek G, Wideł M, Ratuszna A, Habdas J, Kuś P. Photodynamic effects of two water soluble porphyrins evaluated on human malignant melanoma cells in vitro. Acta Biochim Pol. 2003;50:1165–1174
  31. Kramer-Marek G, Szurko A, Serpa C, et al. Spectroscopic studies and singlet oxygen quantum yields of synthetic porphyrin derivatives—potential novel photodynamic therapy agents. Phys Med. 2004;XX(Suppl. 1):46–48
  32. Kramer-Marek G, Serpa C, Szurko A, et al. Spectroscopic properties and photodynamic effects of new lipophilic porphyrin derivatives: efficacy, localization and cell death pathways. J Photochem Photobiol. 2006;B84:1–14
  33. Idziak D, Pasewicz A, Koloczek J, et al. Molecular structure of 5, 10, 15, 20-tetra(1-naphthyl) porphyrin and 5, 10-di(4-hexadecyloxyphenyl)-15, 20-di(4-pyridyl) porhyrin studied by high-energy X-ray diffraction. Chem Phys Lett. 2007;446:36–42
  34. Pasewicz , Idziak D, Koloczek J, et al. Pair correlation function analysis of 5-(4-hexadecyloxyphe-nyl)-10, 15, 20-tri(4-pirydyl) porphyrin and 5-(4-methoxycarbonylphenyl)-10, 15, 20 tri(4-pirydyl) porphyrin. J Mol Struct. 2008;875:167–172
  35. Szurko A, Rams M, Sochanik A, et al. Spectroscopic and biological studies of a novel synthetic chlorin derivative with prospects for use in PDT. Bioorg Med Chem. 2009;[wysłane do druku]
  36. Domaniecki J., et al. The use of photodynamic method in the treatment of malignant melanoma and merkel cell carcinoma. IPA’98, Nantes, France.
  37. Graczyk A, et al. Progress in photodynamic of tumors diagnosis and treatment. Proceedings of SPIE, vol. 4238; 2000.
  38. Graczyk A, et al. Diaminoacid derivatives of protoporfiryne used as photosensitizers in photodynamic method of tumor diagnosis and treatment.
  39. Shu Ye, et al. Investigation of photo-physical properties of selected diaminoacid protoporphyrin derivatives (PP(AA)2Arg2). I. Determination of quantum yield of fluorescence. Opt Appl. 2003;XXXIII(2–3):
  40. Shu Ye, et al. Investigation of photo-physical properties of selected diaminoacid protoporphyrin derivatives (PP(AA)2Arg2). II. Determination of singlet oxygen FD. Opt Appl. 2003;XXXIII(2–3):
  41. Bombalska A, Graczyk A. Interaction of protoporphyrin IX and its derivatives with benzodiazepine receptor. Photodiagn Photodyn Ther. 2009;6
  42. Korbelik M, Krosl G, Krosl J, Dougherty GJ. Role of host lymphoid populations in the response of mouse emt6 tumour to photodynamic therapy. Cancer Res. 1996;56:5647–5652
  43. de Vree WJA, Essers MC, de Bruijn HS, Star WM, Koster JF, Sluite W. Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 1996;56:2908–2911
  44. Golab J, Wilczynski G, Zagozdzon R, et al. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Br J Cancer. 2000;82:1485–1491
  45. Jalili A, Makowski M, Switaj T, et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res. 2004;10:4498–4508
  46. Golab J, Olszewska D, Mroz P, et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin Cancer Res. 2002;8:1265–1270
  47. Makowski M, Nowis D, Golab J. Cytoprotective mechanisms in photodynamic therapy. In:  Uzdensky A editors. Photodynamic therapy at the cellular level. Kerala: Research Signpost; 2007;p. 97–113
  48. Golab J, Nowis D, Skrzycki M, et al. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor. J Biol Chem. 2003;278:407–414
  49. Makowski M, Grzela T, Niderla J, et al. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Clin Cancer Res. 2003;9:5417–5422
  50. Gomer CJ, Luna M, Ferrario A, Rucker N. Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation. Photochem Photobiol. 1991;53:275–279
  51. Nowis D, Legat M, Grzela T, et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity. Oncogene. 2006;25:3365–3374
  52. Kocanova S, Buytaert E, Matroule JY, et al. Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis. 2007;12:731–741
  53. Nowis D, Golab J. Photodynamic therapy and oxidative stress. In:  Hamblin M,  Mroz P editor. Advances in photodynamic therapy: basic, translational, and clinical. Boston, London: Artech House; 2008;p. 151–178
  54. Szokalska A, Makowski M, Nowis D, et al. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res. 2009;69:4235–4243
  55. Sieroń A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med. 2003;32:330–336
  56. Sieroń A, Namysłowski G, Misiołek M, Adamek M, Kawczyk-Krupka A. Kliniczna odpowiedź po zastosowaniu terapii fotodynamicznej w leczeniu zmian przednowotworowych i zaawansowanych raków głowy i szyi. Otolaryngol Pol. 2003;57(4):501–504
  57. Niepsuj K, Niepsuj G, Cebula W, et al. Autofluorescence endoscopy for detection of high-grade dysplasia in short-segment Barrett's esophagus. Gastrointest Endosc. 2003;58(5):715–719
  58. Szyguła M, Wojciechowski B, Adamek M, et al. Fluorescent diagnosis of urinary bladder cancer—a comparison of two diagnostic modalities. Photodiagn Photodyn Ther. 2004;1:23–26
  59. Jalili A, Makowski M, Świtaj T, et al. Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res. 2004;10:4498–4508
  60. Olejek A, Rembielak-Stawecka B, Kozak-Darmas I, Biniszkiewicz T, Sieroń A. Diagnostyka i terapia fotodynamiczna w ginekologiii - aktualny stan wiedzy. Ginekol Pol. T.75(3):228–34.
  61. Latocha M, Piława B, Dudek J, et al. Free radicals in melanotic human melanoma and human colon adenocarcinoma cells after photodynamic therapy. Phys Med. 2004;XX(Suppl. 1):61–63
  62. Senczenko W, Drzazga Z, Sieroń A, Szyguła M, Adamek M. Measurement of disposition of intensivity of laser radiation in PDT—optimal conditions for therapy. Phys Med. 2004;XX(Suppl. 1):58–60
  63. Szyguła M, Wojciechowski B, Adamek M, et al. Photodynamic vs. autofluorescent diagnosis of urinary bladder using Xillix Life System. Phys Med. 2004;XX(Suppl. 1):55–57
  64. Sieroń A, Adamek M, Biniszkiewicz T, et al. Diagnostyka fluorescencyjna i terapia fotodynamiczna w ośrodku wielospecjalistycznym – sześcioletnie doświadczenia własne. Pol Arch Med Wew 2004;T.112, Materiały XXXV Zjazdu TIP: 339–46.
  65. Sieroń A, Adamek M, Wiczkowski A, Dyla Ł, Mazur S, Wierucka-Młynarczyk B. Photodynamic destruction of Porphyromonas gingivalis induced by delta-aminolaevulinic acid. Prog Biomed Opt Imag 2004;5(28) [Proc. SPIE vol. 5610 218-223, 2003 druk].
  66. Sieroń A, Pietrusa A, Szyguła M, et al. Zastosowanie metod fotodynamicznych w urologii. Urol Pol. 2004;57(4):16–20
  67. Szyguła M, Pietrusa A, Adamek M, et al. Combined treatment of urinary bladder cancer with the use of photodynamic therapy (PDT) and subsequent BCG-therapy: a pilot study. Photodiagn Photodyn Ther. 2004;1(3):241–246
  68. Sieroń A, Kawczyk-Krupka A, Adamek M, et al. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of malignant skin tumors. Photodiagn Photodyn Ther. 2004;1:311–317
  69. Adamek M, Kawczyk-Krupka A, Mostowy A, et al. Topical ALA-PDT modifies neutrophils’ chemiluminescence, lymphocytes’ interleukin-1beta secretion and serum level of transforming growth factor beta 1 in patients with nonmelanoma skin malignancies. A clinical study. Photodiagn Photodyn Ther. 2005;2(1):65–72
  70. Biniszkiewicz T, Olejek A, Kozak-Darmas I, Sieroń A. Therapeutic effects of 5-ALA-induced photodynamic therapy in vulvar lichen sclerosus. Photodiagn Photodyn Ther. 2005;2(2):157–160
  71. Latos W, Zieleźnik W, Sieroń-Stołtny K, et al. Planoepithelial papilloma of the esophagus detected in 5 patients in own material of 2582 endoscopies in 2004. Gastroenterol Pol. 2005;12(5):1–4
  72. Sieron A, Gibinski P, Pustelny T, et al. Optical biopsy using spectral camera in BCC and oral leukoplakia. Photodiagn Photodyn Ther. 2008;5(December (4)):271–275[Epub 2008 November 8]
  73. Sieroń A, Kościarz-Grzesiok A, Waśkowska J, et al. The role of autofluorescence diagnostics in the oral mucosa diseases. Photodiagn Photodyn Ther. 2008;5(September (3)):182–186[Epub 2008 October 31]
  74. Lipiński M, Markowski M, Różański W. The value of photodynamic diagnosis (PDD) in identifying carcinoma In situ (Cis) of urinary bladder. Clin Exp Med Lett. 2008;49(1):55–57
  75. Lipiński M, Jeromin L. Comparison of the bladder tumour antigen test with photodynamic diagnosis in patients with pathologically confirmed recurrent superficial urinary bladder tumours. BJU Int. 2002;89:757–759
  76. Lipiński M, Jeromin LM. Photodynamic Laser therapy in refractory transitional cell carcinoma of urinary bladder—early results. Med Laser Appl. 2003;18:173–174
  77. Lipiński M, Jeromin LM. Experiences in the use of photodynamic method in the diagnosis of superficial urinary bladder tumours. Urologia. 2005;XI(2):17–21
  78. Lipiński M, Jeromin LM. Photodynamic therapy of superficial urinary bladder tumours. Urologia. 2005;XI(4):21–26
  79. Lipiński M, Jeromin LM. Over 5 years experience of photodynamic diagnosis (PDD) in superficial urinary bladder tumours (BT). BJU Int. 2002;90(Suppl. 2):199
  80. Lipiński M, Jeromin LM. Early results in photodynamic laser therapy of superficial urinary bladder tumours. BJU Int. 2002;90(Suppl. 2):144
  81. Jeromin L, Peszyński-Drews C, Lipiński M. Photodynamic therapy of bladder tumors with new photosensitizer—photolon pilot study. Acta Bio-Opt Inform Med. 2004;10(1–2):21

PII: S1572-1000(09)00062-3

doi: 10.1016/j.pdpdt.2009.07.003

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 2 , Pages 73-78 , June 2009

Article Tools